Skip to Content

Federated Hermes Inflation Ptctd Sec C RRFCX

Medalist Rating as of | See Federated Hermes Investment Hub
  • NAV / 1-Day Return 9.31  /  −0.21 %
  • Total Assets 105.3 Mil
  • Adj. Expense Ratio
    1.380%
  • Expense Ratio 1.380%
  • Distribution Fee Level Below Average
  • Share Class Type Level Load
  • Category Inflation-Protected Bond
  • Credit Quality / Interest Rate Sensitivity
  • Min. Initial Investment 1,500
  • Status Open
  • TTM Yield 2.96%
  • Effective Duration

USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 10:21 PM GMT+0

Morningstar’s Analysis RRFCX

Will RRFCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Federated Hermes Inflation Ptctd Sec C's Average People Pillar and Process Pillar ratings are n't enough to prevent other weaknesses from sending this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RRFCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 51.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

2 Year Treasury Note Future Mar 24

27.65 41.2 Mil
Government

Us 5yr Note (Cbt) Mar24 Xcbt 20240328

6.57 9.8 Mil
Government

United States Treasury Notes 2.375%

5.56 8.3 Mil
Government

United States Treasury Notes 1.625%

5.19 7.7 Mil
Government

United States Treasury Notes 0.5%

5.15 7.7 Mil
Government

United States Treasury Notes 1.125%

4.60 6.8 Mil
Government

United States Treasury Notes 0.125%

4.50 6.7 Mil
Government

United States Treasury Notes 0.625%

4.19 6.2 Mil
Government

United States Treasury Notes 0.875%

4.11 6.1 Mil
Government

United States Treasury Notes 0.75%

3.94 5.9 Mil
Government